Deep Track Capital's Ownership in Palisade Bio, Inc.

Deep Track Capital, LP, along with its related entities and David Kroin, filed a Schedule 13G disclosing their ownership in Palisade Bio, Inc. As of October 8, 2025, they collectively own 9.99% of the company's common stock, amounting to 10,012,958 shares. The ownership includes 6,428,571 pre-funded warrants subject to a 9.99% maximum percentage exercise limitation. Deep Track Capital, LP and David Kroin may be deemed beneficial owners of a combined 6,428,571 common shares and 6,428,571 pre-funded warrants. Deep Track Biotechnology Master Fund, Ltd. owns 2,925,000 common shares and 6,428,571 pre-funded warrants, while Deep Track Special Opportunities Fund, LP owns 3,503,571 common shares. The filing certifies that the securities were not acquired to influence the control of the issuer.